Synchron Stock
Synchron is a brain computer interface platform company leading the field of implantable neural interface technology, pioneering the development of endovascular minimally invasive neuroprostheses for the treatment of paralysis.
Sign up for SecondMarket® to view the market and buy or sell Synchron Stock
Buy + SellSynchron Stock Price Chart
The below graph shows the estimated historical Synchron stock price as of last month, known as the Tape D® price. The Synchron Tape D® price is based on market activity, publicly-sourced valuation data, and other proprietary information. Create an account to see the current estimated Synchron price per share.
Synchron Funding
Sign up to gain insights into Synchron funding history, including the funding round, time period, and amount raised.
Sign Up to Unlock the Data| Financing Round | Date | Amount | Price per share* | Valuation* |
|---|---|---|---|---|
| Series C | Dec 15, 2022 | 75.00M | ||
| Series B | Jun 03, 2021 | 4.00M | ||
| Series B | Jun 03, 2021 | 36.00M | ||
| Series A | Apr 04, 2017 | 10.00M |
See Synchron Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Synchron Stock Valuation + Share Prices
View real-time Tape D® data on Synchron stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket trading platform.
Get Started
Synchron Management Team
-
Chief Medical Officer
J Mocco
-
Chief Operating Officer
Amos Meltzer
-
Co-Founder, Board Member
Rahul Sharma
-
Board Member
Alex Morgan
-
Chairman of the Board
Martin Dieck
-
Co-Founder, CEO, Board Member
Thomas Oxley
-
Board Member
Nicholas Opie
-
CTO
Riki Banerjee
-
Chief Commercial Officer
Kurt Haggstrom
-
Board Member
Ari Nowacek
Synchron Major Investors
-
Forepont Capital Partners
-
University of Melbourne
-
Neurotechnology Investors (NTI)
-
General Advance
-
Alumni Ventures
-
Project X
-
Subversive Capital
-
Reliance Digital Health Limited
-
Gates Frontier
-
Shanda Group
-
ID8 Investments
-
Khosla Ventures
-
Moore Strategic Ventures
-
Greenoaks
-
Bezos Expeditions
-
METIS
-
Khosla Ventures
-
ARCH Venture Partners
Learn More About Synchron Stock
Buy Synchron Stock
01Synchron stock does not trade on public stock exchanges. Synchron stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Synchron stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Sell Synchron Stock
02Synchron Stock does not trade on public stock exchanges. In order to sell Synchron shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Synchron Stock Price
03Nasdaq Private Market estimates that Synchron price per share was $38.09 last month. This Synchron share value estimate (known as the Tape D™ price) is based on market activity, publicly-sourced valuation data, and other proprietary information. With Tape D premium for investors, you can get visibility into the Synchron share price today and the factors driving Synchron valuation estimates. Learn more about premium data here.
Read more about private company stock prices: Understanding the Bid-Ask Spread: How Buyers and Sellers Match on Price
Synchron Stock Ticker Symbol
04There is no ticker symbol for Synchron stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Criteria to Sell Synchron Stock
05Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Synchron stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Criteria to Buy or Invest in Synchron Stock
06Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Synchron stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Synchron Stock Settlement
07Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Synchron IPO
08Synchron is a private company and has not had an IPO. There is currently no Synchron IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Synchron IPO.
Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.
Sign up for SecondMarket® to view the market and buy or sell Synchron Stock
Buy + Sell*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.
